Big Tech Blocks Women’s Health

Close-up of a persons mouth covered with tape that reads CENSORED FREEDOM

Over 600 women’s health leaders are sounding the alarm that Big Tech’s censorship algorithms are blocking life-saving medical information, forcing legitimate health companies out of business while misinformation spreads unchecked—and now they’re taking the fight to European regulators.

Story Snapshot

95% of women’s health creators surveyed experienced censorship in the past year, with medically accurate content misclassified as “adult content”
Women’s health companies face revenue collapse—HANX reports 80% ad rejection rates threatening business survival, while Hertility saw drastic traffic declines after Meta’s February 2026 restrictions
Women’s Health Visibility Alliance formed by major brands including Essity, Clue, and Hertility files formal complaint with European Commission alleging Digital Services Act violations
Platform censorship forces women to self-diagnose using unproven products while evidence-based health information remains systematically suppressed

Big Tech’s Algorithmic Bias Targets Women’s Health Content

Social media platforms are systematically censoring medically accurate women’s health information through automated moderation systems that misclassify educational content as inappropriate. Posts covering menstruation, fertility, menopause, postpartum recovery, and sexual wellbeing are frequently removed or shadow-banned despite containing peer-reviewed medical information. The CensHERship campaign documented this widespread suppression through an 18-month investigation, revealing that over half of affected creators now self-censor their language to avoid algorithmic punishment. This represents a troubling example of unchecked corporate power silencing legitimate health discourse through opaque technological systems.

Evidence-Based Businesses Collapse While Misinformation Thrives

The economic impact on women-led health companies reveals the real-world consequences of platform censorship. HANX, an eight-year-old company providing evidence-based products, faces existential threats with 80 percent of advertisements rejected before publication. Hertility experienced devastating website traffic declines following Meta’s February 2026 advertising restrictions, despite building its business on peer-reviewed science and clinical evidence. Meanwhile, as CEO Deirdre O’Neill notes, misinformation spreads freely across these same platforms. This creates a perverse marketplace where scientifically sound health companies struggle to survive while unproven products face no comparable restrictions—a clear market distortion caused by biased moderation policies.

Public Health Crisis From Perpetuated Stigma

Medical professionals warn that platform censorship perpetuates dangerous stigma with life-threatening consequences. Dr. Aziza Sesay emphasizes that women are dying of embarrassment, delaying medical care due to shame and presenting with poorer health outcomes when they finally seek help. Dr. Hannah Ditchfield from Sheffield University connects this digital censorship to longstanding offline inequality in women’s health treatment. Women control the majority of household spending globally yet remain strikingly underserved relative to their economic power, according to Clue CEO Rhiannon White. The systematic suppression of accessible health knowledge forces women into self-diagnosis and navigation of confusing marketplaces filled with unproven products—a public health failure enabled by corporate moderation policies.

Coalition Escalates Fight to European Regulators

Women’s health organizations have escalated beyond industry dialogue to formal regulatory action. The newly formed Women’s Health Visibility Alliance, representing major brands including Essity’s Bodyform, Clue, Hertility, Daye, and Mooncup, has lodged a formal complaint with the European Commission alleging systematic non-compliance with the Digital Services Act. Parliamentary roundtables have convened with women’s health brands, academics, creators, and platform representatives, though only TikTok participated. Platform responses remain defensive—Meta claims policies don’t prevent ads but limit sensitive information sharing, while Google encourages appeals for erroneous enforcement. CensHERship co-founder Clio Wood frames the stakes clearly: visibility is fundamental to public health, innovation, and gender equity, not merely a preference.

Constitutional Concerns About Corporate Speech Control

This censorship episode exemplifies broader concerns about unchecked corporate power over public discourse that conservatives have long warned against. When private platforms wield monopolistic control over information access, their content moderation policies function as de facto speech regulation without constitutional constraints or democratic accountability. The systematic suppression of legitimate medical information while misinformation circulates freely reveals the fundamental problem with trusting Silicon Valley algorithms to determine what Americans can see and share. Women’s health represents just one category affected by this broader pattern of ideological and algorithmic bias. The European Commission complaint may establish important precedent, but Americans should demand their own regulatory frameworks ensuring that corporate content policies don’t override citizens’ ability to access truthful, constitutionally protected health information.